Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
509
datasets available to search
ShareScore release 0.9.0
Dataset results
509 results for “Hepatitis C Virus”
Study of Hepatitis C Virus (HCV) Nonstructural Protein 5a (NS5A) Inhibitor IDX719 in Healthy and HCV-Infected Participants (MK-1894-001)
ClinicalTrials.gov study NCT01508156. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Real World Study: Genotype 1 Chronic Hepatitis C Virus Treatment and Evaluation of Real World SVR and PRO
ClinicalTrials.gov study NCT02461745. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Study of ABT-333 in Both Healthy Volunteers and Hepatitis C Virus (HCV) + Genotype 1 Infected Subjects
ClinicalTrials.gov study NCT00696904. IPD Sharing: Not stated. Countries: 0. Publications: 1.
Sofosbuvir Plus Ribavirin Administered for Either 12 or 24 Weeks in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT01838590. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Follow-up Assessment of Resistance to ABT-333 in Hepatitis C Virus (HCV)-Infected Subjects Who Have Received ABT-333 in ABT-333 Studies
ClinicalTrials.gov study NCT00726882. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Status of Chronic Liver Disease in Hepatitis C Virus (HCV) Patients Coinfected With Human Immunodeficiency Virus (HIV) in Andalusia
ClinicalTrials.gov study NCT02511496. IPD Sharing: Not stated. Countries: 0. Publications: 1.
A Rollover Study for Subjects Participating in the Control Arm of Study VX06-950-106, VX05-950-104 and VX05-950-104EU Whose Plasma Hepatitis C Virus (HCV) Ribonucleic Acid (RNA) Levels Did Not Respond
ClinicalTrials.gov study NCT00535847. IPD Sharing: Not stated. Countries: 8. Publications: 0.
Anticoagulation in Liver Fibrosis in Patients With Hepatitis C Virus Infection
ClinicalTrials.gov study NCT00180674. IPD Sharing: NO. Countries: 1. Publications: 0.
Study to Investigate Pharmacokinetics, Safety and Efficacy of Sofosbuvir/Velpatasvir/Voxilaprevir (SOF/VEL/VOX) Fixed Dose Combination (FDC) in Adolescents and Children With Chronic Hepatitis C Virus
ClinicalTrials.gov study NCT03820258. IPD Sharing: YES. Countries: 3. Publications: 0.
Hepatitis C Virus (HCV) Treatment Completion or Withdrawal
ClinicalTrials.gov study NCT00674492. IPD Sharing: Not stated. Countries: 1. Publications: 0.
An Observational Study of Peginterferon Alfa-2a Plus Ribavirin for Hepatitis C Virus (HCV) Infection in Austria
ClinicalTrials.gov study NCT02515279. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety, Pharmacokinetics, and Efficacy of Combination Treatment of AL-335, Odalasvir, and Simeprevir in Japanese Participants With Chronic Hepatitis C Genotype 1 or 2 Virus
ClinicalTrials.gov study NCT02993250. IPD Sharing: Not stated. Countries: 1. Publications: 0.
480 STUDY: Phase 2b Study of Locteron Plus Ribavirin to Treat Hepatitis C Virus (HCV)
ClinicalTrials.gov study NCT00953589. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Sofosbuvir Plus Ribavirin in Treatment-Naive and Treatment-Experienced Egyptian Adults With Chronic Genotype 4 Hepatitis C Virus (HCV) Infection
ClinicalTrials.gov study NCT01713283. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Prevalence of Seroconversion of Hepatitis c Virus Among Children With CKD on Regular Hemodialysis
ClinicalTrials.gov study NCT06104046. IPD Sharing: Not stated. Countries: 0. Publications: 2.
Safety, Tolerability, and Antiviral Activity of ACH-0141625 or Placebo in Combination With Peginterferon and Ribavirin in Hepatitis C Virus (HCV) Positive Participants
ClinicalTrials.gov study NCT01180790. IPD Sharing: Not stated. Countries: 2. Publications: 0.
Pattern of Skin Manifestations in Chronic Hepatitis c Virus Patients Before and After Direct Acting Anti Viral Drugs
ClinicalTrials.gov study NCT03170076. IPD Sharing: NO. Countries: 0. Publications: 4.
Hepatitis C Virus Self-testing (HCVST) in Sexual and Gender Minorities in Rio de Janeiro
ClinicalTrials.gov study NCT06203925. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of pegInterferon Alfa-2a, Ribavirin, and Daclatasvir (BMS-790052) With or Without BMS-650032 for Participants in Some Hepatitis C Virus Trials
ClinicalTrials.gov study NCT01428063. IPD Sharing: Not stated. Countries: 19. Publications: 0.
Viral Kinetics, Interferon Stimulated Genes (ISGs) and mirRNA Among Subjects Infected With Different Hepatitis C Virus Genotypes During Therapy With Sofosbuvir and GS-5816
ClinicalTrials.gov study NCT02468648. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.